Abstract
Background A 36-year-old male presented with bilateral, anterior, chronic uveitis, with cystoid macular edema. Decimal visual acuity was 0.25 in the right eye and 0.20 in the left eye. Ankylosing spondylitis had been diagnosed 13 years previously, with peripheral and axial involvement. He had no history of extra-articular manifestations of ankylosing spondylitis before this uveitis attack. Treatment with the anti-tumor necrosis factor agent etanercept was initiated 5 months before the attack of uveitis.
Investigations Slit-lamp biomicroscopy, laser-flare photometry, optical coherence tomography, chest radiography, angiotensin-converting-enzyme test, mycobacterial culture from gastric lavage, serology tests for syphilis, brucellosis, toxoplasmosis, toxocarosis, antinuclear antibodies, rheumatoid factor, antineutrophil cytoplasmic antibodies, antimyeloperoxydase antibodies and antiproteinase 3 antibodies.
Diagnosis Atypically severe HLA-B27-positive uveitis, in a patient with ankylosing spondylitis treated with etanercept.
Management Intensive topical corticosteroid and cycloplegic treatment, subtenon triamcinolone acetonide injection, switch in treatment from etanercept to infliximab followed by discontinuation of tumor necrosis factor inhibitors, intravenous pulses of methylprednisolone followed by oral corticosteroids, and intravenous cyclophosphamide.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Chang JH et al. (2005) Acute anterior uveitis and HLA-B27. Surv Ophthalmol 50: 364–388
Braun J et al. (2005) Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 52: 2447–2451
Monnet D et al. (2004) Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 111: 802–809
Ladas JG et al. (2005) Laser flare-cell photometry: methodology and clinical applications. Surv Ophthalmol 50: 27–47
Jabs DA et al. (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140: 509–516
Markomichelakis NN et al. (2004) Patterns of macular edema in patients with uveitis, qualitative and quantitative assessment using optical coherence tomography. Ophthalmology 111: 946–953
El-Shabrawi Y and Hermann J (2002) Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. Ophthalmology 109: 2342–2346
Sfikakis PP et al. (2001) Effect of infliximab on sight-threatening panuveitis in Behcet's disease. Lancet 358: 295–296
Smith JR et al. (2001) Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 45: 252–257
Reddy AR and Backhouse OC (2003) Does etanercept induce uveitis? Br J Ophthalmol 87: 925
Tiliakos AN and Tiliakos NA (2003) Ocular inflammatory disease in patients with RA taking etanercept: is discontinuation of etanercept necessary? J Rheumatol 30: 2727
Kasner L et al. (1993) The paradoxical effect of tumor necrosis factor alpha (TNF-alpha) in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 34: 2911–2917
Sfikakis PP et al. (2005) Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum 52: 2513–2518
Haraoui B (2005) Differentiating the efficacy of tumor necrosis factor inhibitors. J Rheumatol Suppl 74: 3–7
Benitez-Del-Castillo JM et al. (2000) Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye 14 (Pt 3A): 340–343
Mohan N et al. (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44: 2862–2869
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Monnet, D., Moachon, L., Dougados, M. et al. Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis. Nat Rev Rheumatol 2, 393–397 (2006). https://doi.org/10.1038/ncprheum0225
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0225
This article is cited by
-
Differenzialdiagnose der anterioren intraokularen Entzündung
Spektrum der Augenheilkunde (2016)
-
Differenzialdiagnose der anterioren intraokularen Entzündung
Der Ophthalmologe (2016)